Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Centers for Medicare & Medicaid Services (CMS)
Pharma
CMS, Incyte settle lawsuit on classification of Opzelura
Incyte has dropped a lawsuit against the CMS, as the agency has agreed not to classify Opzelura together with Jakafi.
Kevin Dunleavy
Jun 23, 2026 1:32pm
Fierce Healthcare
CMS proposal would lock in Medicare drug price negotiations
Jun 12, 2026 5:50pm
Fierce Healthcare
HHS ramps up AI use cases, with most in pre-deployment: BPC
Jun 11, 2026 2:00pm
Fierce Healthcare
CMS delays Part D GLP-1 model amid skepticism from insurers
Apr 22, 2026 12:00pm
Fierce Healthcare
CMS extends application deadline for Medicaid drug pricing model
Mar 2, 2026 3:00pm
AbbVie sues HHS, CMS over Botox's inclusion in IRA price talks
Feb 12, 2026 1:45am